{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5e8c1453f335f8fc5483e9ce/65dfc906d88a940015a08bb9?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Core outcome sets for osteoarthritis trials with Prof Toby Smith","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5e8c1453f335f8fc5483e9ce/1709159127880-f957c2e3d44dbb8ae6ad91d11f790ec9.jpeg?height=200","description":"<p>On today’s episode of Joint Action, we are joined by Professor <a href=\"https://warwick.ac.uk/fac/sci/med/staff/tsmith/\" rel=\"noopener noreferrer\" target=\"_blank\">Toby Smith</a> to discuss core outcome sets in osteoarthritis trials. Toby is Professor of Clinical Trials at the Warwick Clinical Trials Unit, University of Warwick. His current research areas include exploring the rehabilitation of people after hip and knee surgery, trauma, and persistent pain.</p><p><br></p><p><br></p><p>RESOURCES</p><p>Journal articles</p><ul><li><a href=\"https://www.oarsijournal.com/article/S1063-4584(24)00026-8/fulltext\" rel=\"noopener noreferrer\" target=\"_blank\">Adoption of core outcome sets in osteoarthritis clinical trials: Still a long way to go</a></li><li><a href=\"https://pubmed.ncbi.nlm.nih.gov/30647185/\" rel=\"noopener noreferrer\" target=\"_blank\">The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis</a></li><li><a href=\"https://pubmed.ncbi.nlm.nih.gov/30824657/\" rel=\"noopener noreferrer\" target=\"_blank\">Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017</a></li></ul><p>Website</p><ul><li><a href=\"https://omeract.org/\" rel=\"noopener noreferrer\" target=\"_blank\">OMERACT</a></li></ul><p><br></p><p>CONNECT WITH US</p><ul><li>Twitter/X: <a href=\"https://twitter.com/ProfDavidHunter\" rel=\"noopener noreferrer\" target=\"_blank\">@ProfDavidHunter</a> <a href=\"https://twitter.com/jointactionorg\" rel=\"noopener noreferrer\" target=\"_blank\">@jointactionorg</a></li><li>Instagram: <a href=\"https://open.acast.com/networks/60076074795a1c638da15d99/shows/5e8c1453f335f8fc5483e9ce/episodes/www.instagram.com/profdavidhunter\" rel=\"noopener noreferrer\" target=\"_blank\">@ProfDavidHunter</a></li><li>Email: <a href=\"mailto:hello@jointaction.info\" rel=\"noopener noreferrer\" target=\"_blank\">hello@jointaction.info</a></li><li>Website: <a href=\"https://www.jointaction.info/podcast\" rel=\"noopener noreferrer\" target=\"_blank\">www.jointaction.info/podcast</a></li></ul>","author_name":"David Hunter, PhD, FRACP (Rheum)"}